Իսրայել - եբրայերեն - Ministry of Health

teva pharmaceutical industries ltd, israel - cilazapril as monohydrate; hydrochlorothiazide - טבליה - cilazapril as monohydrate 5 mg; hydrochlorothiazide 12.5 mg - cilazapril - cilazapril - treatment of essential hypertension in patients who have been stabilized on the individual components given in the same proportions.

Իսրայել - եբրայերեն - Ministry of Health

sam-on ltd - passiflora; pyridoxine (vit b6) hydrochloride; thiamine (vit b1); valerian dry extract - טבליה - thiamine (vit b1) 10 mg; passiflora 250 mg; valerian dry extract 60 mg; pyridoxine (vit b6) hydrochloride 10 mg - pyridoxine (vit b6) - pyridoxine (vit b6) - sedative in states of tension, nervousness and insomnia.

Իսրայել - եբրայերեն - Ministry of Health

teva pharmaceutical indust.ltd - amiloride as hydrochloride 5 mg; hydrochlorothiazide 50 mg - tablets - hydrochlorothiazide and potassium-sparing agents - hypertension: kaluril is indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of the disease. edema: edema associated with congestive heart failure and hepatic cirrhosis.

Իսրայել - եբրայերեն - Ministry of Health

romat ltd - cyanocobalamin 1 mg/ml; thiamine (vit b1) hydrochloride 100 mg/ml - solution for injection - vitamin b1, 12 supplement in cattle, horses, swine, sheep, dogs and cats.

Իսրայել - եբրայերեն - Ministry of Health

glaxo smith kline (israel) ltd - ropinirole as hydrochloride 2 mg - film coated tablets - prolonged release - ropinirole - ropinirole is indicated for the treatment of parkinson's disease. ropinirole is effective as early therapy in patients requiring dopaminergic therapy. as adjunctive treatment to l-dopa, ropinirole enhances the efficacy of l-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic l-dopa therapy and permits reduction in daily l-dopa dose.

Իսրայել - եբրայերեն - Ministry of Health

glaxo smith kline (israel) ltd - ropinirole as hydrochloride 8 mg - film coated tablets - prolonged release - ropinirole - ropinirole is indicated for the treatment of parkinson's disease. ropinirole is effective as early therapy in patients requiring dopaminergic therapy. as adjunctive treatment to l-dopa, ropinirole enhances the efficacy of l-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic l-dopa therapy and permits reduction in daily l-dopa dose.

Իսրայել - եբրայերեն - Ministry of Health

glaxo smith kline (israel) ltd - ropinirole as hydrochloride 4 mg - film coated tablets - prolonged release - ropinirole - ropinirole is indicated for the treatment of parkinson's disease. ropinirole is effective as early therapy in patients requiring dopaminergic therapy. as adjunctive treatment to l-dopa, ropinirole enhances the efficacy of l-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic l-dopa therapy and permits reduction in daily l-dopa dose.

Իսրայել - եբրայերեն - Ministry of Health

teva pharmaceutical industries ltd, israel - cilazapril as monohydrate; hydrochlorothiazide - טבליה - cilazapril as monohydrate 5 mg; hydrochlorothiazide 12.5 mg - cilazapril - cilazapril - treatment of essential hypertension in patients who have been stabilized on the individual components given in the same proportions.

Իսրայել - եբրայերեն - Ministry of Health

teva pharmaceutical indust.ltd - candesartan cilexetil 16 mg; hydrochlorothiazide 12.5 mg - tablets - candesartan - essential hypertension, where montherapy with candesartan cilexetil or hydrochlorothiazide is not sufficient.

Իսրայել - եբրայերեն - Ministry of Health

eldan electronic instruments co ltd - ioflupane - תמיסה להזרקה - ioflupane 74 mbq/ml - iodine ioflupane (123i) - other dopaminergic agents - datscan is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum: - of patients with clinically uncertain parkinsonian syndromes in order to help differentiate essential tremor from parkinsonian syndromes related to idiopathic parkinson's disease multiple system atrophy and progressive supranuclear palsy. - datscan is unable to discriminate between parkinson's disease multiple system atrophy and progressive supranuclear palsy. - to help differentiate probable dementia with lewy bodies from alzheimer's disease. datscan is unable to discriminate between dementia with lewy bodies and parkinson's disease dementia